| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking?
|
J Am Coll Cardiol
|
2011
|
3.86
|
|
2
|
Survival with cardiac-resynchronization therapy in mild heart failure.
|
N Engl J Med
|
2014
|
3.80
|
|
3
|
J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance.
|
J Am Coll Cardiol
|
2008
|
2.87
|
|
4
|
Preventing sudden death of athletes with electrocardiographic screening: what is the absolute benefit and how much will it cost?
|
J Am Coll Cardiol
|
2012
|
2.84
|
|
5
|
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.
|
Heart Rhythm
|
2010
|
2.79
|
|
6
|
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
|
Circulation
|
2011
|
2.56
|
|
7
|
Fever-induced Brugada pattern: how common is it and what does it mean?
|
Heart Rhythm
|
2013
|
2.25
|
|
8
|
Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands.
|
Circulation
|
2011
|
2.23
|
|
9
|
Efficacy of quinidine in high-risk patients with Brugada syndrome.
|
Circulation
|
2004
|
2.14
|
|
10
|
Inaccessibility to quinidine therapy is about to get worse.
|
J Am Coll Cardiol
|
2013
|
2.12
|
|
11
|
What do we know about the "malignant form" of early repolarization?
|
J Am Coll Cardiol
|
2013
|
2.11
|
|
12
|
To the editor--Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine.
|
Heart Rhythm
|
2010
|
2.10
|
|
13
|
The top 10 reasons to avoid defibrillation threshold testing during ICD implantation.
|
Heart Rhythm
|
2008
|
2.07
|
|
14
|
Distinguishing "benign" from "malignant early repolarization": the value of the ST-segment morphology.
|
Heart Rhythm
|
2011
|
1.90
|
|
15
|
Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.
|
J Am Coll Cardiol
|
2011
|
1.89
|
|
16
|
Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors.
|
Medicine (Baltimore)
|
2003
|
1.78
|
|
17
|
The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization.
|
J Mol Cell Cardiol
|
2010
|
1.78
|
|
18
|
The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
|
J Am Coll Cardiol
|
2007
|
1.69
|
|
19
|
Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
|
Pacing Clin Electrophysiol
|
2009
|
1.59
|
|
20
|
Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.
|
J Cardiovasc Electrophysiol
|
2004
|
1.48
|
|
21
|
Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant.
|
Heart Rhythm
|
2012
|
1.46
|
|
22
|
Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene.
|
Heart Rhythm
|
2011
|
1.46
|
|
23
|
The site of origin of torsade de pointes.
|
Heart
|
2011
|
1.45
|
|
24
|
Radiofrequency ablation of atrioventricular nodal reentry tachycardia: a 14 year experience with 901 patients at the Tel Aviv Sourasky Medical Center.
|
Isr Med Assoc J
|
2006
|
1.42
|
|
25
|
Risk of sudden death among young individuals with J waves and early repolarization: putting the evidence into perspective.
|
Heart Rhythm
|
2011
|
1.40
|
|
26
|
Arrhythmogenic right ventricular cardiomyopathy: an unusual possible cause of arrhythmia in a 78 year old man with a 40 year history of palpitations.
|
Isr Med Assoc J
|
2014
|
1.39
|
|
27
|
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug.
|
J Am Coll Cardiol
|
2004
|
1.28
|
|
28
|
Does Tpeak-Tend provide an index of transmural dispersion of repolarization?
|
Heart Rhythm
|
2007
|
1.23
|
|
29
|
Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
|
Heart Rhythm
|
2007
|
1.20
|
|
30
|
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
|
Europace
|
2015
|
1.13
|
|
31
|
The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option?
|
Pacing Clin Electrophysiol
|
2002
|
1.08
|
|
32
|
Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia.
|
Heart Rhythm
|
2012
|
1.06
|
|
33
|
Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction.
|
Heart Rhythm
|
2007
|
1.04
|
|
34
|
Management of patients with palpitations: a position paper from the European Heart Rhythm Association.
|
Europace
|
2011
|
0.93
|
|
35
|
Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 Years of Age): a scientific statement from the American Heart Association and the American College of Cardiology.
|
Circulation
|
2014
|
0.92
|
|
36
|
Making sense of early repolarization.
|
Heart Rhythm
|
2011
|
0.92
|
|
37
|
Wearable cardioverter-defibrillators.
|
Circulation
|
2013
|
0.92
|
|
38
|
Frequency of spontaneous and inducible atrioventricular nodal reentry tachycardia in patients with idiopathic outflow tract ventricular arrhythmias.
|
Pacing Clin Electrophysiol
|
2006
|
0.91
|
|
39
|
Rationale for the use of the terms J-wave syndromes and early repolarization.
|
J Am Coll Cardiol
|
2011
|
0.91
|
|
40
|
Radiofrequency ablation of accessory pathways: a 14 year experience at the Tel Aviv Medical Center in 508 patients.
|
Isr Med Assoc J
|
2007
|
0.91
|
|
41
|
EP testing does not predict cardiac events in Brugada syndrome.
|
Heart Rhythm
|
2011
|
0.90
|
|
42
|
Congenital absence of left atrial appendage.
|
J Cardiovasc Electrophysiol
|
2014
|
0.89
|
|
43
|
Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator.
|
Europace
|
2012
|
0.88
|
|
44
|
Genetic predisposition and cellular basis for ischemia-induced ST-segment changes and arrhythmias.
|
J Electrocardiol
|
2007
|
0.88
|
|
45
|
Brugada syndrome in children: don't ask, don't tell?
|
Circulation
|
2007
|
0.87
|
|
46
|
The cardiologists' worst nightmare sudden death from "benign" ventricular arrhythmias.
|
J Am Coll Cardiol
|
2005
|
0.86
|
|
47
|
Incidence of dual AV node physiology following termination of AV nodal reentrant tachycardia by adenosine-5'-triphosphate: a comparison with drug administration in sinus rhythm.
|
Indian Pacing Electrophysiol J
|
2003
|
0.86
|
|
48
|
Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association.
|
Circulation
|
2016
|
0.86
|
|
49
|
Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology.
|
J Am Coll Cardiol
|
2014
|
0.84
|
|
50
|
Propoxyphene-induced torsades de pointes.
|
Heart Rhythm
|
2011
|
0.83
|
|
51
|
When u say "U Waves," what do u mean?
|
Pacing Clin Electrophysiol
|
2004
|
0.83
|
|
52
|
J waves and early repolarization: do not confuse me with the facts!
|
Heart Rhythm
|
2012
|
0.82
|
|
53
|
Catheter-induced mechanical trauma to fast and slow pathways during radiofrequency ablation of atrioventricular nodal reentry tachycardia: incidence, predictors, and clinical implications.
|
Pacing Clin Electrophysiol
|
2007
|
0.82
|
|
54
|
Quinidine: a valuable medication joins the list of 'endangered species'.
|
Europace
|
2007
|
0.81
|
|
55
|
Drug challenge with epinephrine or isoproterenol for diagnosing a long QT syndrome: should we try this at home?
|
J Cardiovasc Electrophysiol
|
2005
|
0.80
|
|
56
|
Idiopathic ventricular fibrillation "Le Syndrome d'Haïssaguerre" and the fear of J waves.
|
J Am Coll Cardiol
|
2009
|
0.80
|
|
57
|
The acquired Brugada syndrome and the paradox of choice.
|
Heart Rhythm
|
2009
|
0.79
|
|
58
|
Explaining sudden unexplained death.
|
Circ Arrhythm Electrophysiol
|
2012
|
0.79
|
|
59
|
Post-tachycardia QT prolongation: maladjustment of the QT interval to the normal heart rate.
|
Pacing Clin Electrophysiol
|
2003
|
0.79
|
|
60
|
Atrioventricular block during radiofrequency catheter ablation of atrial flutter: incidence, mechanism, and clinical implications.
|
Europace
|
2011
|
0.78
|
|
61
|
The phenomenon of "QT stunning": the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome.
|
Heart Rhythm
|
2012
|
0.78
|
|
62
|
Long-term prognosis of inducible ventricular flutter: not an innocent finding.
|
Am Heart J
|
2004
|
0.78
|
|
63
|
Inducible ventricular fibrillation in the Brugada syndrome: diagnostic and prognostic implications.
|
J Cardiovasc Electrophysiol
|
2003
|
0.77
|
|
64
|
Effects of head-up tilt-table test on the QT interval.
|
Ann Noninvasive Electrocardiol
|
2010
|
0.77
|
|
65
|
Response of QT interval in methadone maintenance treated patients to the rapid changes in heart rate provoked by brisk standing: comparison to healthy controls and patients with long QT syndrome.
|
J Electrocardiol
|
2013
|
0.76
|
|
66
|
SCN5A mutation associated with acute myocardial infarction.
|
Leg Med (Tokyo)
|
2009
|
0.76
|
|
67
|
Treating the long-QT syndrome in the era of implantable defibrillators.
|
Circulation
|
2009
|
0.76
|
|
68
|
Risk of sudden death in asymptomatic Brugada syndrome: not as high as we thought and not as low as we wished…but the contrary.
|
J Am Coll Cardiol
|
2010
|
0.76
|
|
69
|
Reply: is the J wave or the ST slope malignant…or neither?
|
J Am Coll Cardiol
|
2013
|
0.76
|
|
70
|
Implantable cardioverter defibrillator in high-risk long QT syndrome patients.
|
J Cardiovasc Electrophysiol
|
2003
|
0.75
|
|
71
|
Reply: To PMID 23194938.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
72
|
Brugada burden in Brugada syndrome: the way to go in risk stratification?
|
Heart Rhythm
|
2013
|
0.75
|
|
73
|
Rebuttal to EP testing predicts cardiac events in patients with Brugada syndrome.
|
Heart Rhythm
|
2011
|
0.75
|
|
74
|
Drug-induced prolongation of the QT interval.
|
N Engl J Med
|
2004
|
0.75
|
|
75
|
Should the 'adenosine-challenge test' be part of the routine work-up for syncope?
|
Europace
|
2007
|
0.75
|
|
76
|
Reply: life-threatening events during endurance sports: is heat stroke more prevalent than arrhythmic death?
|
J Am Coll Cardiol
|
2015
|
0.75
|
|
77
|
The degree of potassium channel blockade and the risk of torsade de pointes: the truth, nothing but the truth, but not the whole truth.
|
Eur Heart J
|
2005
|
0.75
|
|
78
|
Hereditary arrhythmia corner: learning from challenging patients. Family with suspect LQTS.
|
Ann Noninvasive Electrocardiol
|
2010
|
0.75
|
|
79
|
An "aggressive" protocol of programmed ventricular stimulation for selecting post-myocardial infarction patients with a low ejection fraction who may not require implantation of an automatic defibrillator.
|
Isr Med Assoc J
|
2009
|
0.75
|
|
80
|
Sports and arrhythmias: a report of the International Workshop Venice Arrhythmias 2009.
|
Eur J Cardiovasc Prev Rehabil
|
2010
|
0.75
|
|
81
|
The role of induced sputum in amiodarone-associated interstitial lung diseases.
|
Cardiology
|
2006
|
0.75
|
|
82
|
Successful ablation of right atriofascicular pathway guided by pathway potential recording despite catheter-induced mechanical pathway trauma.
|
Pacing Clin Electrophysiol
|
2010
|
0.75
|
|
83
|
"Typical" electrocardiographic left ventricular outflow tract ventricular tachycardia ablated from the right heart side.
|
Heart Rhythm
|
2009
|
0.75
|
|
84
|
Reentry in a pulmonary vein as a possible mechanism of focal atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2004
|
0.75
|
|
85
|
Prevention of cardiac arrest: risk assessment after myocardial infarction.
|
Card Electrophysiol Rev
|
2002
|
0.75
|
|
86
|
Reply: Long-QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia: A Tale of 3 Diseases : Ibutilide as a Torsade de Pointes Stress Test.
|
J Am Coll Cardiol
|
2016
|
0.75
|